
A sophisticated positive airway pressure device that automatically adjusts to treat central sleep apnea and complex sleep apnea by providing variable pressure support based on breathing patterns.
Adaptive Servo-Ventilation (ASV) is an advanced form of positive airway pressure therapy specifically designed to treat central sleep apnea, complex sleep apnea (treatment-emergent central apnea), and Cheyne-Stokes respiration. Unlike CPAP or BiPAP, ASV continuously monitors breathing patterns and provides variable pressure support that adapts breath-by-breath to stabilize breathing. It provides more support when breathing is weak and less when breathing normalizes, effectively smoothing out the irregular breathing patterns characteristic of central apneas.
ASV devices use sophisticated algorithms to learn your normal breathing pattern and provide servo-controlled pressure support that varies with each breath. When the device detects weakening breaths or an impending central apnea, it increases inspiratory pressure support. When breathing normalizes, support decreases. The device also provides a backup rate to initiate breaths if breathing pauses completely. This dynamic approach stabilizes breathing throughout the night.
ASV is indicated for central sleep apnea, complex sleep apnea (central apneas emerging on CPAP), and Cheyne-Stokes respiration associated with heart failure. IMPORTANT: ASV is contraindicated in patients with symptomatic chronic heart failure with reduced ejection fraction (LVEF ≤45%). Your sleep physician will determine if ASV is appropriate based on sleep study results and cardiac status.
ASV is highly effective at eliminating central apneas and hypopneas that don't respond to CPAP or BiPAP therapy.
For patients with Cheyne-Stokes respiration or periodic breathing, ASV smooths out the crescendo-decrescendo breathing pattern.
When central apneas emerge or persist on CPAP (treatment-emergent CSA), ASV often resolves these events effectively.
The breath-by-breath adjustment provides precisely the support needed at any moment, optimizing therapy while maintaining comfort.
By eliminating central events and stabilizing breathing, ASV can significantly improve sleep quality and reduce arousals.
Most side effects are minor and can often be resolved with simple adjustments.
ASV requires careful programming by experienced clinicians. Initial settings may need adjustment based on therapy data.
The variable pressure support can feel unfamiliar initially. Most patients adapt within 1-2 weeks of consistent use.
Mask discomfort, aerophagia, and dryness can occur as with any PAP therapy.
ASV is contraindicated in patients with symptomatic heart failure and LVEF ≤45%. A major study (SERVE-HF) found increased cardiovascular mortality in this population.
ASV devices are more expensive than CPAP or BiPAP. Insurance coverage requires documentation of central or complex sleep apnea.
Automatically adjusts the expiratory pressure to treat any coexisting obstructive events while providing servo-controlled inspiratory support.
ResMed, Philips, and other manufacturers use different proprietary algorithms. Patients may respond differently to each brand.
Before starting ASV, ensure you've had appropriate cardiac evaluation, including echocardiogram if indicated, to rule out contraindications.
ASV works best with consistent, all-night use. The device learns and adapts to your breathing patterns over time.
ASV therapy requires closer monitoring than CPAP. Attend all follow-up appointments and share therapy data with your sleep team.
If you experience worsening shortness of breath, chest pain, or other cardiac symptoms, contact your healthcare provider immediately.
The breath-by-breath pressure changes feel different from CPAP or BiPAP. Give yourself time to adapt to this sophisticated therapy.
Search our directory for sleep clinics that offer adaptive servo-ventilation (asv).
Search Clinics